These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12815007)
1. The fibroblast growth factor receptor gene Arg388 allele is not associated with early lymph node metastasis of breast cancer. Becker N; Nieters A; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):582-3. PubMed ID: 12815007 [No Abstract] [Full Text] [Related]
2. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Wang J; Stockton DW; Ittmann M Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6169-78. PubMed ID: 15448004 [TBL] [Abstract][Full Text] [Related]
3. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. Naidu R; Har YC; Taib NA J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142 [TBL] [Abstract][Full Text] [Related]
4. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661 [TBL] [Abstract][Full Text] [Related]
5. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray]. Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527 [TBL] [Abstract][Full Text] [Related]
6. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847 [TBL] [Abstract][Full Text] [Related]
7. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015 [TBL] [Abstract][Full Text] [Related]
8. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440 [TBL] [Abstract][Full Text] [Related]
9. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294 [TBL] [Abstract][Full Text] [Related]
10. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE; Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [TBL] [Abstract][Full Text] [Related]
11. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414 [TBL] [Abstract][Full Text] [Related]
12. Second thoughts on sentinel lymph node biopsy in node-negative breast cancer. Kuijt GP; Roumen RM Br J Surg; 2008 Mar; 95(3):310-1. PubMed ID: 17952887 [No Abstract] [Full Text] [Related]
13. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer. Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400 [TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760 [TBL] [Abstract][Full Text] [Related]
15. [Identification of lymph node metastasis in cancer of the large intestine by differentiating the gene expression profile pattern]. Komuro K Hokkaido Igaku Zasshi; 2004 Nov; 79(6):681-93. PubMed ID: 15675298 [No Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor gene polymorphisms in thyroid cancer. Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537 [TBL] [Abstract][Full Text] [Related]
17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
18. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth]. van der Loo EM; Hop WC; Tervoort MA; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561 [TBL] [Abstract][Full Text] [Related]
19. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer. Yigit E; Gönüllü G; Yücel I; Turgut M; Erdem D; Cakar B Eur J Intern Med; 2008 Dec; 19(8):602-7. PubMed ID: 19046726 [TBL] [Abstract][Full Text] [Related]
20. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance]. Hu SE; Zhang YJ; Cui YM; Zhang HQ Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]